HARBOUR INVESTMENTS, INC. - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
HARBOUR INVESTMENTS, INC. ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$6,201
-15.7%
39
-25.0%
0.00%
Q2 2023$7,356
-69.2%
52
-63.4%
0.00%
-100.0%
Q1 2023$23,907
+45.6%
142
+46.4%
0.00%0.0%
Q4 2022$16,423
+2.6%
970.0%0.00%0.0%
Q3 2022$16,0000.0%970.0%0.00%0.0%
Q2 2022$16,000
-30.4%
97
+14.1%
0.00%0.0%
Q4 2021$23,000
-23.3%
85
-19.0%
0.00%0.0%
Q3 2021$30,000
+36.4%
105
-5.4%
0.00%0.0%
Q2 2021$22,000
-38.9%
111
-39.7%
0.00%0.0%
Q1 2021$36,0001840.00%
Other shareholders
REPLIGEN CORP shareholders Q1 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders